JP2009538614A5 - - Google Patents

Download PDF

Info

Publication number
JP2009538614A5
JP2009538614A5 JP2009512739A JP2009512739A JP2009538614A5 JP 2009538614 A5 JP2009538614 A5 JP 2009538614A5 JP 2009512739 A JP2009512739 A JP 2009512739A JP 2009512739 A JP2009512739 A JP 2009512739A JP 2009538614 A5 JP2009538614 A5 JP 2009538614A5
Authority
JP
Japan
Prior art keywords
antibacterial activity
peptide
concentration
amino acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009512739A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009538614A (ja
Filing date
Publication date
Priority claimed from ZA200604035A external-priority patent/ZA200604035B/xx
Application filed filed Critical
Priority claimed from PCT/IB2007/051982 external-priority patent/WO2007138538A2/en
Publication of JP2009538614A publication Critical patent/JP2009538614A/ja
Publication of JP2009538614A5 publication Critical patent/JP2009538614A5/ja
Pending legal-status Critical Current

Links

JP2009512739A 2006-05-28 2007-05-25 プロバイオティクス菌株及びこれに由来する抗菌性ペプチド Pending JP2009538614A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA200604035A ZA200604035B (en) 2005-05-31 2006-05-28 Improved grenade launcher
PCT/IB2007/051982 WO2007138538A2 (en) 2006-05-28 2007-05-25 Probiotic strain and antimicrobial peptide derived therefrom

Publications (2)

Publication Number Publication Date
JP2009538614A JP2009538614A (ja) 2009-11-12
JP2009538614A5 true JP2009538614A5 (enExample) 2010-06-24

Family

ID=38779065

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009512739A Pending JP2009538614A (ja) 2006-05-28 2007-05-25 プロバイオティクス菌株及びこれに由来する抗菌性ペプチド

Country Status (13)

Country Link
US (2) US7951385B2 (enExample)
EP (1) EP2021457B1 (enExample)
JP (1) JP2009538614A (enExample)
KR (1) KR101521123B1 (enExample)
CN (1) CN101454440B (enExample)
AP (1) AP2841A (enExample)
AU (1) AU2007266675B2 (enExample)
CA (1) CA2647161A1 (enExample)
EA (1) EA017558B1 (enExample)
IL (2) IL195520A0 (enExample)
NO (1) NO20084577L (enExample)
NZ (1) NZ571619A (enExample)
WO (1) WO2007138538A2 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009538614A (ja) * 2006-05-28 2009-11-12 シプラ メドプロ リサーチ アンド デヴェロップメント (プロプライエタリー) リミテッド プロバイオティクス菌株及びこれに由来する抗菌性ペプチド
US8357519B2 (en) * 2008-11-19 2013-01-22 The Ohio State University Methods and processes for producing esters
WO2011045764A1 (en) * 2009-10-15 2011-04-21 Cipla Medpro Research And Development (Pty) Ltd A product for delivering antimicrobially active substances to an infected site
JP5881017B2 (ja) * 2010-11-05 2016-03-09 国立大学法人広島大学 籾殻または玄米から単離された植物乳酸菌およびその利用
WO2012148891A1 (en) * 2011-04-29 2012-11-01 Evonik Degussa Corporation Peptide-lipid conjugates and uses thereof
RU2532227C1 (ru) * 2013-10-23 2014-10-27 Федеральное бюджетное учреждение науки Государственный научный центр прикладной микробиологии и биотехнологии (ФБУН ГНЦ ПМБ) Штамм enterоcoccus mundtii, продуцирующий субстанцию пептидной природы с антилистериозной активностью
RU2599430C1 (ru) * 2015-07-23 2016-10-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Горский государственный аграрный университет" ШТАММ ЛАКТОБАКТЕРИЙ Enterococcus mundtii - ПРОДУЦЕНТ МОЛОЧНОЙ КИСЛОТЫ И АНТИБИОТИЧЕСКИХ ВЕЩЕСТВ
US9944960B2 (en) * 2015-11-17 2018-04-17 Premier Research Labs, Lp Process for microbial production of dihydrolipoic acid and extraction of dihydrolipoic acid with edible oils
CN105385636A (zh) * 2015-12-07 2016-03-09 江南大学 一株产细菌素的肠膜明串珠菌及其应用
JP2019510036A (ja) 2016-03-31 2019-04-11 ゴジョ・インダストリーズ・インコーポレイテッド プロバイオティクス/プレバイオティクス有効成分を含む清浄剤組成物
EP3436156A1 (en) 2016-03-31 2019-02-06 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
KR101722255B1 (ko) * 2016-04-22 2017-04-03 주식회사 폴인브레드 쌀과 쌀누룩을 이용한 자연발효종 제조방법
US11564879B2 (en) 2016-11-23 2023-01-31 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
WO2019060115A1 (en) * 2017-09-19 2019-03-28 Advaxis, Inc. COMPOSITIONS AND METHODS FOR LYOPHILIZATION OF BACTERIA OR LISTERIA STRAINS
WO2019151371A1 (ja) * 2018-01-31 2019-08-08 ニュートリー株式会社 肺炎球菌感染症の予防及び/又は治療剤
KR102076089B1 (ko) 2018-10-02 2020-02-11 서울대학교 산학협력단 니신 z 생산능이 우수한 락토코커스 락티스 서브스페시스 락티스 ldtm 6804 신균주(kctc 13564bp)
CN109456911B (zh) * 2018-10-10 2019-10-18 南京林业大学 一株蒙氏肠球菌HcM7及其应用
CN110846260B (zh) * 2019-12-18 2021-03-02 江南大学 一株降低生物胺的肉葡萄球菌及其应用
KR20240115407A (ko) * 2023-01-18 2024-07-26 조선대학교산학협력단 오리 유래 항균 펩타이드로부터 설계된 신규 항균 펩타이드 및 이의 용도

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1084969A (ja) 1996-09-19 1998-04-07 Chemo Sero Therapeut Res Inst ヘモフィルス・パラガリナルム由来新規ポリペプチド及びその製法
US7655775B2 (en) * 1997-09-05 2010-02-02 Canbiocin, Inc. Expression vectors for treating bacterial infections
AU7898700A (en) 1999-10-22 2001-05-08 Shanghai Bio Road Gene Development Ltd. A novel polypeptide-rna binding protein 33 and polynucleotide encoding said polypeptide
GB0027761D0 (en) 2000-11-14 2000-12-27 Nestle Sa Nutritional composition for an immune condition
DE10105347A1 (de) * 2001-02-05 2002-08-22 Nutrinova Gmbh Sorbinsäurepräparat enthaltend Probiotika als Futtermittelzusatz in der Nutztieraufzucht
GB0125535D0 (en) 2001-10-24 2001-12-12 Microbiological Res Authority Mycobacterial genes down-regulated during latency
US6878373B2 (en) 2001-12-03 2005-04-12 Micropure Technologies, Inc. Probiotic composition containing Bacillus cereus RRRL B-30535
JP4111489B2 (ja) * 2002-05-23 2008-07-02 プリマハム株式会社 新規バクテリオシン
WO2004005492A2 (fr) * 2002-07-03 2004-01-15 Galina Gennadievna Alekhina Composition probiotique a base d'une souche d'enterocoques pour moyens de traitement et de prevention et procede de fabrication correspondant
EP1384483A1 (en) * 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
ITBO20020564A1 (it) 2002-09-06 2004-03-07 Alfa Wassermann Spa Bifidobatteri e preparazioni che li contengono.
JP2009538614A (ja) * 2006-05-28 2009-11-12 シプラ メドプロ リサーチ アンド デヴェロップメント (プロプライエタリー) リミテッド プロバイオティクス菌株及びこれに由来する抗菌性ペプチド

Similar Documents

Publication Publication Date Title
JP2009538614A5 (enExample)
US7713726B2 (en) Inhibition of pathogens by probiotic bacteria
CA2389982C (en) Inhibition of pathogens by bacillus coagulans strains
EP2176284B1 (en) Lantibiotics and uses thereof
EP3795169B1 (en) Bacteriophage-derived recombinant protein having antimicrobial activity against pathogenic gram-negative bacteria
JP5622110B2 (ja) 新規乳酸菌
Saleem et al. Comparative study of two bacteriocins produced by representative indigenous soil bacteria.
US8410046B2 (en) Antibiotic peptide derived from ribosomal protein L1 of Helicobacter pylori and use thereof
KR20190010054A (ko) 항균 활성을 갖는 스타필로코커스 갈리나럼 균주 및 이의 항균 용도
US12102666B2 (en) Use of recombinant antibacterial protein Ablysin for effectively killing multidrug-resistant pathogenic bacteria
CN111320678B (zh) 抗菌肽突变体及其应用
US12220448B2 (en) Method of treating pathogenic bacterial infectious diseases
KR102275801B1 (ko) 시스-자스몬을 포함하는 바이오필름 형성 억제용 조성물
US20240293482A1 (en) Compositions and methods for treating biofilms, infections and periodontitis
KR20060108964A (ko) 엔테로코커스 패칼리스 cbt―sl(5), 이를 이용한항균 배양액 분리농축물의 제조 방법 및 이를 포함하는조성물
KR102342160B1 (ko) 탁시폴린을 포함하는 바이오필름 형성 억제용 조성물
KR102637772B1 (ko) 위건강과 구강질환 관련 미생물 및 병원성 미생물에 대한 항균활성을 갖는 산삼 유래 락토바실러스 플란타럼 wg.q7 균주 및 이의 용도
US9802982B2 (en) Peptide and uses thereof
KR102441377B1 (ko) 펙토리나린을 포함하는 바이오필름 형성 억제용 조성물
US20230381249A1 (en) Probiotic strain for countering caries pathogens
Xiaodong et al. Optimisation of culture conditions for antagonism of Vancomycin-resistant Staphylococcus aureus by Streptococcus D-19 of upper respiratory tract
CN120201999A (zh) 抗微生物组合物
CZ2017797A3 (cs) Terapeutický prostředek na bázi bakteriálních lyzátů
UA32120C2 (uk) Біопрепарат для лікування і профілактики захворювань слизових оболонок і шкірних покривів